Gilead Sciences (NASDAQ:GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada ...

"The CDC must be investigated for its misuse of PEPFAR funds," said Sen. Jim Risch (R-Idaho), following a report that funds ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will ...

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...

In April 2021, the CDC came to Charleston — the seat of Kanawha County and the state capital, tucked into the confluence of the Kanawha and Elk rivers — to investigate dozens of newly detected HIV ...

A major U.S. HIV/AIDS relief program is facing potential blowback amid reports that the program was used to fund abortions in southeast Africa.

Jose Abrigo, Esq., HIV Project Director of the Lambda Legal Defense and Education Fund explains the biggest HIV issues anticipated this year.

In its litigation, the government alleged Gilead (GILD) had overstated its contribution in developing a preventive HIV regimen with the drug, ignored the CDC's contributions and failed to license ...